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ABStrACt 
Introduction: The Sysmex® XE-2100D is a multiparameter hematology analyzer designed for hematology testing in samples with 
ethylenediamine tetraacetic acid (EDTA). Objectives: Considering the importance of this hematology analyzer for clinical and laboratory 
practice, the objective of this study was to evaluate its analytical performance, comparing the obtained results with quality specifications 
described in literature. Material and method: In the evaluation of analytical performance, according to recommendations of the document 
H26-A2 of the Clinical and Laboratory Standards Institute (CLSI), intra-run imprecision, inter-run imprecision, linearity, carryover, 
autosampler evaluation, clinical sensitivity of the atypical lymphocytes flag (n = 400 samples) were included, as well as the comparison 
between automated and manual leukocyte differential count (n = 400 samples), based on an adaptation of the document H20-A2 of 
CLSI. Results: Repeatability, reproducibility, linearity and carryover were satisfactory according to the manufacturer’s specifications. The 
clinical sensitivity of the atypical lymphocytes flag showed efficiency, sensitivity and specificity of 92.5%, 65.2% and 94.1% respectively. The 
correlation coefficients between the automated and manual differential counts of neutrophils, lymphocytes, monocytes, eosinophils and 
basophils were 0.991, 0.99, 0.872, 0.974 and 0.557, respectively. Conclusions: The results were in accordance with quality specifications 
described in literature, indicating reliability in Sysmex® XE-2100D. This fact ensures certainty to both laboratory professionals and medical 
staff. We conclude that the Sysmex® XE-2100D showed excellent analytical performance, and is useful to provide reliable hematology data.
Key words: automation; hematology analyzer; Sysmex® XE-2100d; analytical performance; quality control.
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introDuCtion
One of the most important discoveries in the development 
of hematology analyzers was the formulation of the principle of 
electrical impedance, patented by the American engineer Wallace 
Henry Coulter on October 20, 1953. Originally created to count 
the number of particles in dairies, the impedance method was 
soon adapted to count blood cells, especially due to the increased 
demand for blood tests. That made it possible to reduce time of 
cell counting from 30 minutes to 15 seconds when compared to 
manual microscopic methods, and to reduce counting errors by a 
factor of 10. In 1963, seven years after the Coulter Counter model 
A (Coulter Electronics, Hialeah, Florida), the first hematology 
analyzer, became commercially available, a small factory in the 
Japanese town of Kobe, initially called TOA Medical Electronics and 
since 1998 renamed Sysmex Corporation, developed and launched 
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a new hematology analyzer, called Microcell Counter, model 
CC-1001. In order to avoid the use of the impedance principle, 
patented by Coulter, Sysmex then developed the capacitance 
method, that would be replaced by impedance as soon as Coulter’s 
patent expired in 1976(10, 12, 23, 28).
More than 40 years went by since hematology parameters 
began being measured by automated methods. During those 
years analyzers continually evolved due to companies’ efforts 
and abilities to meet the market needs, and to scientific processes 
related to the peripheral technologies necessary to make such 
development possible. Sysmex XE-2100D is a fully automated 
hematology analyzer that determines eight validated parameters 
for the red blood cells, 13 for the white blood cells and two for 
platelets that may also be used for body fluid cell counts. It is 
classified as a high-volume hematology analyzer, designed for 
hospitals with intense work routines and for reference laboratories 
that perform thousands of tests per day. It has a nominal capacity of 
approximately 150 tests per hour, besides being able to warn users 
as to the presence of qualitative and quantitative abnormalities in 
blood cell populations. It uses fluorescence flow cytometry with 
light scattering as a principle for differential and total leukocyte 
count. For erythrocyte and platelet count, it uses the principle 
of impedance with hydrodynamic focusing, and for hemoglobin 
measurement, a method with sodium lauryl sulfate (6, 16, 19).
The analytical performance of hematology analyzers is 
traditionally assessed by tests for precision, accuracy, linearity, 
carryover, comparability, reproducibility and clinical sensitivity 
of analyzer-generated flags. When one interprets the results from 
patients’ samples, it is important to understand the possible 
occurrence of random errors or analytical imprecision of the 
results, irrespective of the likely influence of analytical variability 
and patients’ health condition on results. Performance evaluation 
of the automated hematology analyzers must be carried out in all 
laboratories, mainly in those with a large number of samples with 
very high or very low cell counts and that serve populations with 
potential to present relevant blood alterations(5, 7, 8, 15, 26).
Considering that the complete blood count is one of the 
most frequently ordered exams in medical appointments and a 
fundamental exam to detect any pathology that is reflected in the 
blood stream, the validation of results from a hematology analyzer 
becomes an item of special importance, especially for reflecting 
the quality of laboratory work and directly influencing patients 
clinical conduct. Aimed at increasing quality of the complete blood 
count results provided by laboratories, is it necessary to assess the 
analytical performance of hematology analyzers, so as to ensure 
that the obtained results are the most reliable possible.
The objective of this study was to evaluate the analytical 
performance of hematology analyzer Sysmex® XE-2100D, given 
its relevance in laboratory and clinical practices. It is important to 
highlight that this study, besides being a basis upon which other 
hematology laboratories understand the usefulness of validating 
a hematology analyzer, will provide data for the validation of 
hematology analyzers in laboratory routines.
MAtEriALS AnD MEthoDS
Study site, samples and patients 
This study was conducted in the Hematology sector of 
Laboratório Municipal de Análises Clínicas Dr. Gerson Bruschini 
Ribeiro, in the town of Araucária, Paraná. All used samples came 
from residue material of the laboratory routine, randomly selected 
and belonging to patients whose complete blood count was ordered. 
Samples were collected in tubes containing ethylenediamine 
tetraacetic acid dipotassium salt (EDTAK
2
) as anticoagulant. All 
samples were analyzed at the hematology equipment Sysmex® 
XE-2100D within three hours after collection.
Linearity 
This test allowed establishing the linear correlation between 
theoretical values and those observed in practice by means of 
the analysis of several dilutions of a certain sample. Linearity for 
leukocytes and platelets was assessed by the conduction of seven 
dilutions: 1\2; 1\4; 1\8; 1\16; 1\32; 1\64; 1\128 of two samples 
selected from laboratory routine. One sample obtained the 
leukocyte values of  > 65 × 10³/µl, and another sample obtained 
the platelet value of > 730 × 10³/µl. Dilutions were performed 
with the equipment solvent (Cellpack, Sysmex). Prior to dilution 
analysis, Sysmex® XE-2100D was washed with 5% sodium 
hypochlorite and distilled water. Dilutions were homogenized and 
inverted 20 times; afterwards, they were analyzed in duplicate. The 
linear equation and the correlation coefficient between theoretical 
and practical values were calculated for leukocytes and platelets(29).
Carryover 
It indicates, in percentage, how much a sample with high 
results may falsely raise results of a cytopenic sample subsequently 
analyzed. This evaluation was performed in triplicate of a sample 
with high concentration of the analyte in question (H1, H2 e 
H3), with a subsequent analysis in triplicate of a sample with low 
concentration of the same analyte. The percentage of carryover 
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for each parameter was calculated with the following formula: 
carryover (%) = |L1 - L3|/(H3-L3) × 100(3). Where L1 and L3 
were the results of the first and third measurement of samples 
with low concentration, and H3 was the third measurement of the 
sample with high concentration. For leukocytes, the low and the 
high sample contained values of 0.34 × 10³/µl and 100 × 10³/
µl, respectively. For erythrocytes, 1.5 × 106/µl and 6 × 106/µl, 
respectively. For hemoglobin, 4 g/dl and 18g/dl, respectively. For 
globular volume, 14% and 55%, respectively; for platelets, 20 × 
10³/µl and 1,020 × 10³/µl respectively.
Autosampler evaluation
A rack with 10 random samples was analyzed, previously 
homogenized during five minutes. Next, samples were allowed 
to stand in vertical position during four hours. Afterwards, they 
were analyzed directly and with no prior homogenization. Sample 
homogenization was done exclusively by the autosampler, which 
does it by inverting tubes 10 times. Erythrocyte, leukocyte and 
platelet counts were compared. The maximum allowed variations 
between these both procedures were: erythrocytes (± 1.5%), 
leukocytes (± 3%), and platelets (± 5%)(21, 27).
Intra-run imprecision or repeatability 
The objective of this test was to determine the analyzer 
capacity to reproduce the results for a certain parameter in a given 
sample. Analyses were carried out in normal conditions, by the 
same operator, in the same period of the day and with the same 
reagent lots. In order to adequate samples to the analytical ranges 
to be assessed, their dilutions were performed. A sample with 
normal values, one with increased leukocyte values (> 50 × 10³/
µl) and a sample with increased platelet values (> 1,000 × 10³/
µl) were used. The prepared samples were analyzed 10 consecutive 
times in the closed mode of Sysmex® XE-2100D. The mean, the 
standard deviation (SD) and the coefficient of variation (CV) were 
calculated for each parameter. It is worth highlighting that before 
samples were analyzed, the analyzer was washed with 5% sodium 
hypochlorite and distilled water. Prior to the analysis, samples were 
homogenized and inverted 20 times.
Inter-run imprecision or reproducibility
It was aimed at determining the capacity of the analyzer to 
reproduce results of hematological parameters, when samples 
were analyzed several times during the same day or in the course of 
several days. Reproducibility was carried out by analyzing sample 
results of internal quality control through three concentrations 
levels (low, normal and high). Such samples were analyzed during 
57 consecutive days, before the beginning of the routine. At the 
lot expiration date, data were sent to Sysmex external proficiency 
testing, called Insight Program. For each hematologic parameter, 
the mean, SD and CV were calculated.
Comparison between the manual and automated 
differential count of leukocytes 
During a period of five consecutive days, 400 samples were 
collected from routine with their printed results of SysmexÒ XE-
2100D, along with blood smears, so as to allow comparison 
between the manual and automated differential count of 
leukocytes. Blood smears were manually created and stained by 
May-Grünwald and Giemsa method. Manual differential count 
was performed in 400 cells per slide at an optical microscope. This 
count was based on an adaptation of the document CLSI H20-A2(7). 
According to this document, comparisons between manual and 
automated differential leukocyte counts must be performed by 
counting two blood smears of each sample, in which 200 cells are 
counted in each slide by two different observers. In case an 
accentuated difference is observed, a third slide must be created 
and analyzed by a third observer. Just then average percentages 
are calculated for each cell type. In this work 400 cells per slide 
were counted, in a total of 400 blood smears, by a single observer 
only. In an attempt to minimize errors inherent in the technique, 
400 cells per slide were counted, as it was not possible to create 
more than one blood smear per sample. For each slide read, the 
percentage of neutrophils, lymphocytes, monocytes, eosinophils 
and basophils was calculated. The obtained results were compared 
with other studies and with the manufacturer’s specifications.
Clinical sensitivity for atypical lymphocytes flag
Morphologic flag refers to a warning the analyzer emits 
indicating that the sample in analysis may have a relevant 
morphologic abnormality, such as the presence of immature 
cells, which are not normally quantifiable by current hematology 
analyzers. The morphologic flag plays an important role to warn 
about the need to undertake a blood smear review(1). Clinical 
sensitivity for atypical lymphocytes flag was verified in the 400 
samples used for assessment of correlation between the manual and 
automated differential count of leukocytes. The atypical lymphocytes 
flag was chosen for evaluation because of its incidence in the 
analyzed samples. In order to assess performance of this parameter, 
efficacy, sensitivity, specificity, positive predictive value and negative 
predictive value were determined. If a sample was positive for the 
atypical lymphocytes flag and in the microscopic evaluation had ≥ 
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2% of atypical lymphocytes, the sample was classified as true positive 
(TP). If a sample was positive for the atypical lymphocytes flag and 
no atypical lymphocytes ≥ 2% were found at microscopy, the sample 
was classified as false positive(FP). If a sample was negative for the 
atypical lymphocytes flag and had ≥ 2% of atypical lymphocytes in 
the microscopic analysis, the sample was classified as false negative 
(FN). Finally, if a sample was negative for the atypical lymphocytes 
flag and did not present any relevant finding on the slide, the sample 
was classified as true negative (TN)(1, 9, 24).
Statistical analysis
The obtained results were statistically analyzed by using the 
program Excel (Microsoft Corporation, USA). The correlation 
between the manual and automated differential count of leukocytes 
was made by regression analysis, determining the correlation 
coefficient (r) and comparing it with current specifications in 
literature. Sensitivity, specificity, positive predictive value, negative 
predictive value and efficiency related to the clinical sensitivity for 
atypical lymphocytes flag were calculated as follows: sensitivity 
(%) = (VP/VP + FN) × 100; specificity (%) = (VN/VN + FP) × 
100; negative predictive value (%) = (VN/VN + FN) × 100; positive 
predictive value (%) = (VP/VP + FP) × 100; and efficiency (%) = 
(VP + VN/VP + FP + FN + VN) × 100(14). 
rESuLtS
Linearity 
Linearity was verified for leukocytes and platelets, and for both 
it presented an excellent correlation coefficient (0.999) between 
theoretical and observed values (Figure 1).
Carryover
For all the assessed parameters the carryover was ≤ 1%, 
according to the manufacturer’s specifications(27). Results are 
shown in Table 1.
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The average variation between the analyzed samples with or 
without previous homogenization for erythrocytes, leukocytes and 
platelets was 0.51%, 1.34% and 5.38%, respectively. Erythrocytes 
and leukocytes were below the allowed limits of 1.5% and 3%, 
respectively. The variation for platelets was above the allowed 
limit of 5%. 
Intra-run imprecision or repeatability 
Results are presented in Table 2. The CV for repeatability of 
the leukocyte count of 4-10 × 10³/µl was 2%, and for the platelets 
10-20 × 10³/µl it was 6.5%. Globular volume also presented 
satisfactory results, with CV between 0.34% and 0.36%. Intra-run 
imprecision for all levels was acceptable; however, samples with 
low levels demonstrated high CV.
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Inter-run imprecision or reproducibility 
Results are shown in Table 3. There are quality specifications 
that suggest that the maximum intra-analyzer imprecision for 
hematological parameters must be lower than half of the intra-
individual biological variability (CV
(analytical)
 or imprecision < 
0.5 × CV
(intra)
). All the CVs observed in this trial, except relative 
and absolute monocyte count in the three used levels were lower 
than the cited specification(4). Erythrocytes, hemoglobin, globular 
volume and the corpuscular constants showed exceptional 
precision, with CV < 1.5% for the three levels. Neutrophil and 
lymphocyte differential counts were also excellent, with CVs < 5%.
Comparison between the manual and automated 
differential count of leukocytes 
Results were excellent, as can be seen in Figure 2. All 
correlation coefficients were above the limits specified by the 
manufacturer(27).
tABLE 2 – Intra-run imprecision for leukocytes,  













< 1 8.6 10-20 6,5
1-4 3 20-50 5 < 20 0.3
4-10 2 150-400 1 38-45 0.4
10-20 2.4 400-1,000 2 > 50 0.92
> 50 1 > 1,000 1
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figurE 2 – Comparison between the automated (XE-2100D) and the manual (CLSI H20-A2) differential count of leukocytes (n = 400)
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tABLE 3 – Reproducibility results, Sysmex® XE-2100D
Parameters
Low control Normal control High control
SD Mean CV SD Mean CV SD Mean CV
Erythrocytes 0.021 2.31 0.9 0.030 4.36 0.7 0.036 5.27 0.7
Hemoglobin 0.07 5.7 1.2 0.09 11.9 0.8 0.11 15.7 0.7
Globular volume 0.17 17.2 1.0 0.34 35.1 1 0.38 45.3 0.8
MCV 0.52 74.4 0.7 0.45 80.5 0.6 0.42 86 0.5
MCH 0.25 24.5 1.0 0.2 27.4 0.7 0.19 29.8 0.6
MCHC 0.42 32.9 1.3 0.36 34 1.1 0.27 34.7 0.8
RDW 0.13 16.1 0.8 0.08 14.6 0.5 0.07 14.6 0.5
Leukocytes 0.086 2.95 2.9 0.101 6.7 1.5 0.257 16.69 1.5
Neutrophils% 1.25 46.5 2.7 1.04 50.2 2.1 1.08 54.2 2
Lymphocytes% 1.27 34.3 3.7 1.05 29.9 3.5 0.96 26.4 3.6
Monocytes% 0.89 9.8 9.1 1.07 9.4 11.4 1.11 8.1 13.7
Eosinophils% 0.77 9.4 8.2 0.63 10.5 6 0.87 11.3 7.7
Basophils% 1.31 65.6 2.0 1.02 69.9 1.5 0.49 75.8 0.6
Neutrophils# 0.056 1.37 4.1 0.078 3.37 2.3 0.231 9.05 2.6
Lymphocytes# 0.051 1.01 5.0 0.071 2 3.5 0.182 4.41 4.1
Monocytes# 0.028 0.29 9.7 0.075 0.63 11.9 0.182 1.35 13.5
Eosinophils# 0.022 0.28 7.9 0.044 0.7 6.3 0.148 1.88 7.9
Basophils# 0.072 1.94 3.7 0.089 4.68 1.9 0.206 12.65 1.6
Platelets 2.6 55 4.7 4.6 205 2.2 8.5 469 1.8
MPV 0.29 9.1 3.2 0.11 9.3 1.2 0.09 9.4 1
MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW: red cell distribution width;  
%: relative value; #: absolute value; MPV: mean platelet value; SD: standard deviation; CV: coefficient of variation.
tABLE 4 – Clinical sensitivity for the atypical lymphocytes  
flag of the hematology analyzer Sysmex XE®-2100D











Positive predictive value 40.5
Negative predictive value 97.7
Efficiency 92.5
Clinical sensitivity for atypical lymphocytes flag
The values found for efficacy, sensitivity, specificity, positive 
predicted value and negative predictive value are shown in Table 4. 
Efficiency in the classification of samples with or without atypical 
lymphocytes ≥ 2% was 92.5%, that is, of the 400 analyzed samples, 370 
were correctly classified. Specificity of 94.1% indicated that 355 samples 
in 377 that did not present atypical lymphocytes ≥ 2% at microscopy 
(TN + FP) were correctly classified. The negative predictive value 
observed indicated that in 97.7% of the times that the analyzer did not 
generate the atypical lymphocytes flag, the microscopic counterpart 
was not observed either (atypical lymphocytes ≥ 2%).
DiSCuSSion
The linearity study was satisfactory in comparison with 
other studies. Regression lines went through the origin and the 
r values were close to 1, evidencing linearity at very low and very 
high concentrations. Nakul-Aquaronne et al.(22) obtained an r value 
of 0.99 for platelets and 1 for leukocytes in the linearity study at 
top-of-the-line Sysmex XE-2100. In this study, for the 
XE-2100D, the r found was 0.999 for both parameters 
(Figure 1). In the assessment by Walters and Garrity(29), 
Sysmex® XE-2100 showed results similar to these in our study 
(r of 0.997 for leukocytes and 0.998 for platelets). The obtained results 
in this assay have great importance to demonstrate there was a linear 
relationship for leukocytes and platelets in several dilutions during the 
analytical range of Sysmex® XE-2100D.
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The carryover values in this study (Table 2) were satisfactory 
when compared with those recommended by the equipment 
manufacturer(27): the carryover for leukocytes, erythrocytes, 
hemoglobin, globular volume and platelets must be ≤ 1%. Nakul-
Aquaronne et al.(22) observed a carryover of 0.05% for leukocytes 
and 0.04% for platelets at XE-2100. Another study with XE-2100 
found values for leukocytes of 0.04%, erythrocytes of 0.14% and 
platelets of 0.04%, while for globular volume and hemoglobin 
there was no carryover(14). It is worth highlighting that before the 
analysis, washes with hypochlorite and water were made at Sysmex 
XE-2100D so as to avoid a background count. The results of this 
assessment confirmed the efficiency of the wash made between a 
sample analysis and another.
There is a time interval between collection and the 
conduction of the exam, when the tube stands still and erythrocyte 
sedimentation occurs. In order to adequately count the sample, 
it must be homogenized before the exam, in hematologic 
homogenizers for five minutes, especially if the hematologic 
analyzer does not have a sample loader system in racks. In case 
it does, an evaluation of the counter sampler must be done to 
verify the possibility of forgoing previous homogenization, what 
helps decrease sample processing time. The results obtained in 
this study demonstrate that Sysmex XE-2100D sampler was able 
to adequately homogenize samples for erythrocyte and leukocyte 
count. For platelets, the 5.38% result was above the recommended 
limit of 5%. Therefore, a previous sample homogenization is 
recommended before they are analyzed at Sysmex XE-2100D. A 
suggestion to decrease variation would be homogenizing samples 
in the rack, manually, for 10 times, before placing it in the 
hematologic analyzer autosampler.
Intra-run imprecision results were excellent when compared 
with the specifications of the equipment manual(27), which 
indicates that the CV for leukocytes ≥ 4 × 10³/µl must be ≤ 3%. 
In this study the found value was 2% (Table 2), what confirms 
that SysmexÒ XE-2100D has operated beyond the specifications 
defined by the manufacturer. For platelets with counts ≥ 100 × 
10³/µl the precision limit must be ≤ 4% and in this study it was 
≤ 4% (Table 2).The globular volume also presented satisfactory 
results, since the CV must be ≤ 1.5% and the values found in this 
study ranged from 0.34% to 0.36% (Table 2). As expected, for low 
platelet and leukocyte values, CV was higher. Similar results were 
found in the study conducted by Nakul-Aquaronne et al.(22), in 
which precision for low platelet and leukocyte values resulted in 
high CV in analyzers Abbott Cell-Dyn 4000, Sysmex SE-9500 and 
XE-2100. A bigger variation in low counts may happen because 
the low leukocyte and platelet concentrations are on the extreme 
of linearity in this hematologic analyzer, which may be not able 
to perform counts with high precision due to the lower number 
of counted cells, taking into account that the dilution performed 
by the analyzer is always in the same proportion for any sample.
There are quality specifications that recommend intra-
analyzer imprecision may range from 25% to 50% in relation to 
biological variation for a certain parameter; however, when one 
intends to compare results between two different analyzers, the 
acceptable limit of variation must be higher, principally because 
they are independent analytical systems and there is the need to 
consider the existence of small differences in the target values 
of commercial controls for each equipment, when they come 
from different manufacturers or belong to different models, what 
implies small differences in accuracy(9). The determination of 
intra-run imprecision was important to show the analyzer quality 
in test conduction and to confirm the fact that when the sample is 
analyzed more than once, differences will be minimum.
Imprecision, as well as the other tests of analytical performance, 
must be obtained in the environment where the hematologic 
analyzer will work and by the technical staff that will operate it. The 
scope of the evaluations depends, above all, on the hematological 
parameter ranges reported by the laboratory. Hospital laboratories 
must evaluate imprecision in the lower extremes of hematological 
parameters. Platelet count of 10-20 × 103/µl showed intra-
run imprecision of 6.48%, which was better than the previously 
documented imprecision for the platelet count by impedance at 
SysmexÒ XE-2100, which was 13.6% in counts within these ranges(11). 
Nowadays there are analyzers, like the recently launched modular 
system Sysmex XN, with imprecision of just 4% in the platelet count 
by optical fluorescence method in these same intervals(2).
Reproducibility was assessed to document calibration stability 
over time for all the parameters reported in the complete blood 
count. Reproducibility must always be verified in samples with 
several levels of concentration, so as to comprise the analytical 
intervals that occur in the laboratory. As expected, at low levels 
CVs were higher for erythrocytes, leukocytes and platelets due to 
their low concentrations in the blood. The differential count of 
monocytes presented high CVs in the three assessed levels (Table 3). 
Goosens et al.(13) documented the precision problem of monocyte 
count in hematology analyzers, as well as this study; however the 
clinical significance of this imprecision is low.
With the CV values obtained from the internal control and 
with the bias values obtained from the proficiency trial, the total 
allowed error was calculated, as well as the sigma index for all 
parameters. Total error was below that specified in literature for 
all parameters, and the sigma was higher than 3 for all parameters 
(data not presented).
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The comparative study between the XE-2100D manual and 
automated differential count of leukocytes showed excellent 
comparability, even in leukopenic samples. The five-part differential 
count of the XE-2100D is precise, accurate and reliable. The 
correlation coefficient of basophils was 0.557, probably because there 
is a low basophil count in normal people’s blood, what increases 
imprecision in the differential count of this specific parameter. In 
spite of this, the correlation of basophil count was acceptable, for 
the manufacturer recommends the correlation coefficient to be 
≥ 0.5. Studies of leukocyte differential count with XE-2100D were 
not found in literature, but studies performed with XE-2100, which 
uses similar detection principles, showed identical results to those 
of this study(29). The coefficients found in this study for neutrophils, 
lymphocytes, monocytes and eosinophils were 0.991, 0.99, 0.872 
and 0.974, respectively (Figure 2). The manufacturer recommends 
they are higher than 0.9, 0.9, 0.75 and 0.8, respectively. Therefore, 
the performance of Sysmex XE-2100D as regards comparability far 
outweighs the specifications recommended by the manufacturer. 
Just in few cases with low absolute and relative counts imprecision 
increased. Herklotz and Huber(17) made a comparison between 
the manual and automated differential count of XE-2100D by the 
analysis of 500 cells in normal and pathological samples, and the 
correlation was also high for neutrophils and lymphocytes (r > 
0.98) and eosinophils (r = 0.95).
Assessing the efficiency of morphologic flags is of utmost 
importance for laboratories, because it helps professionals that 
analyze blood smears microscopically. Sensitivity for a flag refers 
to the capacity to detect truly positive samples, specificity is the 
capacity to detect truly negative samples, positive predictive value 
is the probability that a positive result is truly positive, and negative 
predictive value is the probability that a negative result is truly 
negative. In order to be useful, a morphologic flag must present 
low rate of false positives and false negatives, so as to result in high 
efficiency to identify samples showing relevant morphological 
abnormalities. However, it is known that there are situations 
when the occurrence of false positive and false negative rates is 
unavoidable. One must maximize efforts to keep false negative 
rates within safe and acceptable limits.
In the present study sensitivity was not very high (65.2%), 
but specificity was very good (94.1%). Ruzicka et al.(24) found 
sensitivity of 36% for atypical lymphocytes flag and suggested that 
the broad morphologic definition of atypical lymphocytes may 
have been responsible for the low sensitivity. Nakul-Aquaronne 
et al.(22) found sensitivity and specificity > 90% and a negative 
predictive value of 98% for atypical lymphocytes flag in the XE-
2100. The value of false negatives for atypical lymphocytes in 
this study was 2%, what demonstrates high quality equipment 
screening. False positive rates were 5.5%, indicating that 22 slides 
in 400 were unnecessarily read.
The type of sample selected for such analysis is an important 
source of variation because they influence the sensitivity and 
specificity of the analyzer being evaluated. The use of outpatients’ 
samples, as in this study, normally has fewer false positive and false 
negative results than that of inpatients’ samples. Laboratory staff 
is recommended to be well-acquainted with the strong and weak 
points of their specific hematology analyzer(18).
In hematology analyzers, the cutoff values to determine 
sensitivity and specificity of flags are adjusted to offer more false 
positive results, because the consequences of errors due to excessive 
analysis of blood smears are less dramatic than omissions of 
information relevant to patients’ diagnosis and follow-up(1). Thus, 
some works proposed a way to maximize flags efficiency, through 
the development of a probability rate that helps in the definition 
of cutoff values set in analyzers, which would minimize the 
occurrence of false negative and false positive values(20, 25).
ConCLuSion
The equipment SysmexÒ XE-2100D proved to be a hematology 
analyzer of high analytical performance, being suitable for 
medium and large laboratories. The results obtained in this study 
indicate the reliability of parameters offered by this analyzer, 
besides certainty in the analysis of blood smears.
rESuMo 
Introdução: O Sysmex® XE-2100D é um analisador hematológico multiparamétrico destinado à realização de testes 
hematológicos em sangue anticoagulado com ácido etilenodiamino tetra-acético (EDTA). Objetivos: Considerando a sua 
importância na prática clínica e laboratorial, o objetivo deste estudo foi avaliar seu desempenho analítico, comparando os 
resultados obtidos com especificações de qualidade descritas na literatura. Material e método: Na avaliação de desempenho 
analítico, conforme recomendações do documento H26-A2 do Clinical and Laboratory Standards Institute (CLSI), foram 
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especificações do fabricante. O ensaio de sensibilidade clínica do alerta morfológico (flag) de linfócitos atípicos mostrou 
eficiência, sensibilidade e especificidade de 92,5%; 65,2% e 94,1% respectivamente. Os coeficientes de correlação entre as 
contagens diferenciais automatizadas e manuais de neutrófilos, linfócitos, monócitos, eosinófilos e basófilos foram de 0,991; 
0,99; 0,872; 0,974 e 0,557 respectivamente. Conclusões: Os resultados obtidos mostraram-se de acordo com as especificações 
da qualidade analítica descritas na literatura, indicando confiabilidade no Sysmex® XE-2100D. Esse fato confere segurança 
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